Cargando…

Chemotherapeutic efficacy of the protein-doxorubicin conjugates on multidrug resistant rat hepatoma cell line in vitro.

In vitro studies were initiated to study the antitumour effect of protein-doxorubicin (DXR) conjugate on the growth of the multidrug resistant rat ascites hepatoma cell line, AH66DR. The 50% inhibitory concentration (IC50) for DXR in AH66DR cell line was 16 mumol l-1 (AH66 parental cell line, AH66P,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohkawa, K., Hatano, T., Tsukada, Y., Matsuda, M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1993
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968189/ https://www.ncbi.nlm.nih.gov/pubmed/8431358

Ejemplares similares

Glutathione-doxorubicin conjugate expresses potent cytotoxicity by suppression of glutathione S-transferase activity: comparison between doxorubicin-sensitive and -resistant rat hepatoma cells.
por: Asakura, T., et al.
Publicado: (1997)

Effects of chemotherapeutic agents on alpha-fetoprotein secretion and growth of human hepatoma cell lines in vitro.
por: Muraoka, A., et al.
Publicado: (1989)

Doxorubicin-transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells
por: Łubgan, Dorota, et al.
Publicado: (2008)

Caspase-3 activation during apoptosis caused by glutathione–doxorubicin conjugate
por: Asakura, T, et al.
Publicado: (1999)

In vitro activity of daunomycin-anti-alphafoetoprotein conjugate on mouse hepatoma cells.
por: Belles-Isles, M., et al.
Publicado: (1980)

Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells
por: Wu, Shaocong, et al.
Publicado: (2018)

A Novel Strategy Conjugating PD-L1 Polypeptide With Doxorubicin Alleviates Chemotherapeutic Resistance and Enhances Immune Response in Colon Cancer
por: Wang, Maolin, et al.
Publicado: (2021)

Luteolin Prevents Cardiac Dysfunction and Improves the Chemotherapeutic Efficacy of Doxorubicin in Breast Cancer
por: Shi, Youyang, et al.
Publicado: (2021)

Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines
por: Karai, Edina, et al.
Publicado: (2020)

Enhancing Anti-Tumor Efficacy of Doxorubicin by Non-Covalent Conjugation to Gold Nanoparticles – In Vitro Studies on Feline Fibrosarcoma Cell Lines
por: Wójcik, Michał, et al.
Publicado: (2015)

Fulvestrant reverses doxorubicin resistance in multidrug-resistant breast cell lines independent of estrogen receptor expression
por: Huang, Yuan, et al.
Publicado: (2017)

Chemotherapeutic Sensitization of Leptomycin B Resistant Lung Cancer Cells by Pretreatment with Doxorubicin
por: Lu, Chuanwen, et al.
Publicado: (2012)

Analysis of the Efficacy of Multidrug Combination Chemotherapy Regimens for Osteosarcoma and the Management of Chemotherapeutic Reactions
por: Tian, Dawei, et al.
Publicado: (2022)

A Novel Model of Solitary Hepatic Tumor in Rats Using Ascites Hepatoma AH13: Suitability for Chemotherapeutic Studies
por: Tamura, Yoshihiro, et al.
Publicado: (1990)

Enhanced therapeutic efficacy of doxorubicin against multidrug-resistant breast cancer with reduced cardiotoxicity
por: Zhang, Tianyu, et al.
Publicado: (2023)

Ginsenoside Rg5 overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter: in vitro and in vivo study
por: Feng, Sen-Ling, et al.
Publicado: (2020)

Inclusion Complexes of Melphalan with Gemini-Conjugated β-Cyclodextrin: Physicochemical Properties and Chemotherapeutic Efficacy in In-Vitro Tumor Models
por: Mohammed-Saeid, Waleed, et al.
Publicado: (2019)

Deposition of Doxorubicin in Rats following Administration of Three Newly Synthesized Doxorubicin Conjugates
por: Huan, Menglei, et al.
Publicado: (2013)

Correction: Enhancing Anti-Tumor Efficacy of Doxorubicin by Non-Covalent Conjugation to Gold Nanoparticles - In Vitro Studies on Feline Fibrosarcoma Cell Lines
por: Wójcik, Michał, et al.
Publicado: (2015)

Immunostimulatory effects on B cells by the chemotherapeutic drug Doxorubicin
por: Kinn, Johan M, et al.
Publicado: (2011)

Importance of Intracellular pH in Determining the Uptake and Efficacy of the Weakly Basic Chemotherapeutic Drug, Doxorubicin
por: Swietach, Pawel, et al.
Publicado: (2012)

A Novel Agent Enhances the Chemotherapeutic Efficacy of Doxorubicin in MCF-7 Breast Cancer Cells
por: Wang, Liang, et al.
Publicado: (2016)

Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer
por: Li, Xiaoguang, et al.
Publicado: (2016)

The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis
por: Zhang, Bin, et al.
Publicado: (2020)

Retracted: Analysis of the Efficacy of Multidrug Combination Chemotherapy Regimens for Osteosarcoma and the Management of Chemotherapeutic Reactions
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Doxorubicin-loaded phosphatidylethanolamine-conjugated nanoliposomes: in vitro characterization and their accumulation in liver, kidneys, and lungs in rats
por: Rudra, Anandamoy, et al.
Publicado: (2010)

SIRT6 Depletion Sensitizes Human Hepatoma Cells to Chemotherapeutics by Downregulating MDR1 Expression
por: Xia, Yang Q., et al.
Publicado: (2018)

A Pharmacological Strategy Using Stemofoline for more Efficacious Chemotherapeutic Treatments Against Human Multidrug Resistant Leukemic Cells
por: Umsumarng, Sonthaya, et al.
Publicado: (2018)

Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
por: Gorini, Stefania, et al.
Publicado: (2018)

Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats
por: Chu, Tian‐Huei, et al.
Publicado: (2018)

Differential modulation of doxorubicin toxicity to multidrug and intrinsically drug resistant cell lines by anti-oestrogens and their major metabolites.
por: Kirk, J., et al.
Publicado: (1993)

Codelivery of Chemotherapeutics via Crosslinked Multilamellar Liposomal Vesicles to Overcome Multidrug Resistance in Tumor
por: Liu, Yarong, et al.
Publicado: (2014)

Relationship between therapeutic efficacy of doxorubicin-transferrin conjugate and expression of P-glycoprotein in chronic erythromyeloblastoid leukemia cells sensitive and resistant to doxorubicin
por: Szwed, Marzena, et al.
Publicado: (2014)

Investigation of Radiotracer Metabolic Stability In Vitro with CYP-Overexpressing Hepatoma Cell Lines
por: Lemm, Sandy, et al.
Publicado: (2022)

Effects of Lipoic Acid, Caffeic Acid and a Synthesized Lipoyl-Caffeic Conjugate on Human Hepatoma Cell Lines
por: Guerriero, Eliana, et al.
Publicado: (2011)

Apoptosis is induced in both drug-sensitive and multidrug-resistant hepatoma cells by somatostatin analogue TT-232
por: Diaconu, C-C, et al.
Publicado: (1999)

Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells
por: HUANG, FANG, et al.
Publicado: (2014)

Cellular Robustness Conferred by Genetic Crosstalk Underlies Resistance against Chemotherapeutic Drug Doxorubicin in Fission Yeast
por: Tay, Zoey, et al.
Publicado: (2013)

In vitro Invasion of Endothelial Cell Monolayer by Rat Ascites Hepatoma Cells
por: Ohigashi, Hiroaki, et al.
Publicado: (1989)

Corrigendum to “Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib”
por: Gorini, Stefania, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_22fvm9uljlcbqkprtqh01q8p57